Skip to main content
. 2017 Jan 31;55(1):722–728. doi: 10.1080/13880209.2016.1268635

Table 3.

Effect of metformin in presence/absence of bicuculline or wortmannin on T2DM-induced changes in the fasting blood glucose and insulin level, HOMA-IR and HOMA-B indices of T2DM rats.

Groups Fasting blood Glucose (mmol/L) Fasting blood Insulin (pmol/L)   HOMA-IR HOMA-B
Control 4.8 ± 0.19   75.2 ± 3.22 2.7 ± 0.32 175.4 ± 13.41
T2DM 25.7 ± 1.23a   122.4 ± 10.21a 21.2 ± 1.29a 15.5 ± 4.85a
T2DM + MET 15.3 ± 1.17a,b   81.4 ± 8.71a,b 10.3 ± 0.33a,b 45.2 ± 3.22a,b
T2DM + MET + BIC 15.5 ± 1.14a,b   80.8 ± 9.15a,b 10.5 ± 1.53a,b 44.8 ± 4.41a,b
T2DM + MET + WAT 26.4 ± 1.43a,c,d   121.8 ± 8.29a,c,d 21.4 ± 1.44a,c,d 13.2 ± 5.23a,c,d
T2DM + BIC 25.9 ± 1.21a,c,d   122.2 ± 7.74a,c,d 19.2 ± 1.52a,c,d 13.2 ± 3.42a,c,d
T2DM + WAT 25.8 ± 1.21a,c,d   121.6 ± 8.73a,c,d 19.1 ± 1.41a,c,d 13.6 ± 4.29a,c,d

All values are mean ± SEM (n = 6).

a

p < 0.05 compared to control,

b

p < 0.05 compared to T2DM,

c

p < 0.05 compared to T2DM + MET and

d

p < 0.05 compared to T2DM + MET + BIC (one-way ANOVA followed by Student–Newman–Keuls test).